Brain pacemaker targets seizures in Drug-Resistant epilepsy
NCT ID NCT07458217
First seen Jun 25, 2026 · Last updated Aug 04, 2026 · Updated 5 times
Summary
This pilot study tests a deep brain stimulation device that sends electrical pulses to two brain areas (STN and CM) to reduce seizures in adults with drug-resistant motor epilepsy. Ten participants will have the device implanted and will be monitored for changes in seizure frequency and any side effects. The goal is to see if this combined stimulation is safe and effective for people whose seizures don't respond to medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- deep brain stimulation device
- What this could lead to
- If successful, this could offer a new way to reduce seizures in people with motor epilepsy that doesn't respond to medication.
- What could go wrong
- This is a very small, early pilot study with only 10 participants, so results may not apply widely. Deep brain stimulation also carries risks like infection or side effects from the implant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOTOR EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.